HGH Fragment 176-191 vs Ipamorelin
Overview
HGH Fragment 176-191 and Ipamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares HGH Fragment 176-191 and Ipamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| HGH Fragment 176-191 | Ipamorelin | |
|---|---|---|
| Category | Performance & Growth | Performance & Growth |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 250-500 mcg | 200-300 mcg |
| Frequency | daily | twice-daily |
| Reported benefits | Targeted fat loss, no impact on insulin or blood sugar | Natural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase |
| Reported side effects | Very well-tolerated | Very well-tolerated. Rare: headache, injection site reactions |
Key differences
Primary use. HGH Fragment 176-191 is categorised under Performance & Growth, while Ipamorelin falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. HGH Fragment 176-191: not FDA-approved; treated as a research compound. Ipamorelin: not FDA-approved; treated as a research compound.
Dosing. HGH Fragment 176-191 is typically dosed at 250-500 mcg (daily). Ipamorelin is typically dosed at 200-300 mcg (twice-daily).
Can you stack them?
Some protocols combine peptides, but stacking HGH Fragment 176-191 and Ipamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between HGH Fragment 176-191 and Ipamorelin?
- HGH Fragment 176-191 and Ipamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. HGH Fragment 176-191 is not FDA-approved; generally classified as a research compound, whereas Ipamorelin is not FDA-approved; generally classified as a research compound.
- What is HGH Fragment 176-191 used for?
- Fat loss without GH effects.
- What is Ipamorelin used for?
- GH secretagogue, anti-aging.
- Can you take HGH Fragment 176-191 and Ipamorelin together?
- Some users combine peptides within a single protocol, but stacking HGH Fragment 176-191 and Ipamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is HGH Fragment 176-191 or Ipamorelin FDA-approved?
- HGH Fragment 176-191 is not FDA-approved; generally classified as a research compound. Ipamorelin is not FDA-approved; generally classified as a research compound.
Read the full articles
- HGH Fragment 176-191 — full monograph: mechanism, research, dosing & references
- Ipamorelin — full monograph: mechanism, research, dosing & references